Abstract:Objective To investigate the effect of retroperitoneal laparoscopy of non-functional incidental suprarenoma on hypertension. Methods Retrospective analysis was done from 2012 October to 2014 October, and patients with adrenal tumor undergoing retroperitoneal laparoscopic resection were as the research objects. The longest follow-up time was 2 years. We observed blood pressure change from preoperation to completion of postoperative follow-up, and operation-related complications. Results During the postoperative follow-up to completion, the blood pressure in 69 patients decreased(88.5%,69/78). The average systolic blood pressure levels decreased from (167.2±5.2) mmHg to (122.1±3.7) mmHg, and the average diastolic blood pressure levels decreased from (100.3±4.6) mmHg to (79.9±2.4) mmHg, and the difference was statistically significant (P<0.001). In patients with initial hypertension at levels 3, 2, 1, their postoperative overall improvement rate were 93.1%, 88.9%, 88.1%, and the differences were no statistically significant. Furthermore, the operation had a low incidence of complications (11 cases,14.1%), not needing medical treatment. Conclusions Retroperitoneal laparoscopic resection of adrenal tumor can relieve a portion of patients with hypertension, and the risk of operation is low.
Young W F Jr. Management approaches to adrenal incidentalomas [J]. Endocrinol Metab Clin North Am, 2000,29(1):159-185.
[1]
Geelhoed G W, Druy E M. Management of the adrenal “incidentaloma”[J].Surgery,1982,92(5):866-874.
[3]
Linos D A. Adrenal incidentaloma (adrenaloma) [J]. Hormones (Athens), 2003, 2: 12-21.
[2]
Young W F Jr. Management approaches to adrenal incidentalomas [J]. Endocrinol Metab Clin North Am, 2000,29(1):159-185.
[4]
Kim J I, Bae K H I, Choi Y K, et al. Clinical characteristics for 348 patients with adrenal incidentaloma [J]. Endocrinol Metab, 2013, 28(1): 20-25.
[3]
Linos D A. Adrenal incidentaloma (adrenaloma) [J]. Hormones (Athens), 2003, 2: 12-21.
[5]
Latronico A C, Chrousos G P. Extensive personal experience: adrenocortical tumors [J]. J Clin Endocrinol Metab, 1997, 82: 1317-1324.
[4]
Kim J I, Bae K H I, Choi Y K, et al. Clinical characteristics for 348 patients with adrenal incidentaloma [J]. Endocrinol Metab, 2013, 28(1): 20-25.
[6]
Young W F Jr. The incidentally discovered adrenal mass [J]. N Engl J Med, 2007, 356: 601-610.
[5]
Latronico A C, Chrousos G P. Extensive personal experience: adrenocortical tumors [J]. J Clin Endocrinol Metab, 1997, 82: 1317-1324.
[7]
Longo D L, Harrison T R. Harrison’s principles of internal medicine[M]. 18 th ed. New York: McGraw-Hill, 2011: 2940-2961.
[6]
Young W F Jr. The incidentally discovered adrenal mass [J]. N Engl J Med, 2007, 356: 601-610.
[8]
Jeong H S, Kim H J, Kim H S, et al. Clinical characteristics for 132 patients with adrenal incidentaloma [J]. J Korean Endocr Soc, 2007, 22: 260-265.
[7]
Longo D L, Harrison T R. Harrison’s principles of internal medicine[M]. 18 th ed. New York: McGraw-Hill, 2011: 2940-2961.
[9]
Carter Y, Roy M, Sippel R S, et al. Persistent hypertension after adrenalectomy for an aldosterone- producing adenoma: weight as a critical prognostic factor for aldosterone’s lasting effect on the cardiac and vascular systems[J]. J Surg Res, 2012, 177(2): 241-247.
[8]
Jeong H S, Kim H J, Kim H S, et al. Clinical characteristics for 132 patients with adrenal incidentaloma [J]. J Korean Endocr Soc, 2007, 22: 260-265.
[10]
Lin Y H, Lee H H, Liu K L, et al. TAIPAI Study Group. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy[J]. Surgery, 2011, 150(3): 526-533.
[9]
Carter Y, Roy M, Sippel R S, et al. Persistent hypertension after adrenalectomy for an aldosterone- producing adenoma: weight as a critical prognostic factor for aldosterone’s lasting effect on the cardiac and vascular systems[J]. J Surg Res, 2012, 177(2): 241-247.
[10]
Lin Y H, Lee H H, Liu K L, et al. TAIPAI Study Group. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy[J]. Surgery, 2011, 150(3): 526-533.